Page last updated: 2024-10-16

curdlan and Leishmaniasis, Visceral

curdlan has been researched along with Leishmaniasis, Visceral in 1 studies

D-hexose : A hexose that has D-configuration at position 5.

Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.

Research Excerpts

ExcerptRelevanceReference
"Curdlan was associated with production of the disease-resolving T-helper (Th) 1 and Th17-inducing cytokines interleukin (IL)-6, IL-1β, and IL-23, as well as with production of Th17 cytokines IL-17 and IL-22, as determined by enzyme-linked immunosorbent assay (ELISA) and real time polymerase chain reaction (RT-PCR)."1.39Successful therapy of visceral leishmaniasis with curdlan involves T-helper 17 cytokines. ( Das, PK; Ghosh, K; Kar, S; Saha, A; Sharma, G; Ukil, A, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ghosh, K1
Sharma, G1
Saha, A1
Kar, S1
Das, PK1
Ukil, A1

Other Studies

1 other study available for curdlan and Leishmaniasis, Visceral

ArticleYear
Successful therapy of visceral leishmaniasis with curdlan involves T-helper 17 cytokines.
    The Journal of infectious diseases, 2013, Mar-15, Volume: 207, Issue:6

    Topics: Animals; Antibodies, Monoclonal; beta-Glucans; Disease Models, Animal; Immunologic Factors; Interfer

2013